Fujifilm Medical Systems USA introduced a comprehensive set of automated remote monitoring services for its Synapse PACS at the Healthcare Information and Management Systems Society annual conference in Orlando, Feb. 22 to 26. Active Monitoring
Fujifilm Medical Systems USA introduced a comprehensive set of automated remote monitoring services for its Synapse PACS at the Healthcare Information and Management Systems Society annual conference in Orlando, Feb. 22 to 26. Active Monitoring continuously and securely monitors and logs performance metrics of a facility's Synapse system. The goal is to proactively detect system anomalies and remedy them before they cause serious problems. Performance metrics include CPU and memory utilization and available disk space. Specific component and status information, including operating system/application version and patch levels, and network address, are monitored and measured against predetermined performance thresholds. When it detects conditions that are out-of-tolerance, Active Monitoring automatically alerts an appointed system administrator, via e-mail or pager, to remedy the issue.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.